KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

The investment companies Fortress Investment Group and Mubadala Investment Company, through a subsidiary of Mubadala Capital, have completed a deal to acquire 90.01% of Fortress shares from SoftBank ...

KELIX Bio, a subsidiary of Mubadala Investment Company, has completed its acquisition of DiabTec, a biomanufacturing facility previously owned by Julphar, one of the UAE’s largest pharmaceutical ...

It also complements KELIX bio’s recent acquisition of four GlobalOne Healthcare Holding assets. About Mubadala Investment Company Mubadala Investment Company is a sovereign investor managing a global ...